Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 413 of 1,261

  1. US 10702602

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  2. US 10702541

    Stimulation of an immune response by enantiomers of cationic lipids

    PDS Biotechnology Corporation · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  3. US 10702525

    Pyrimidine derivatives as anti-diabetic agents

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  4. US 10702532

    Nucleotide analogs

    The Regents of the University of California · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  5. US 10702498

    MU opioid receptor modulators

    The Regents of the University of California · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  6. US 10702535

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  7. US 10702474

    Fusogenic liposome-coated porous silicon nanoparticles

    The Regents of the University of California · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  8. US 10704076

    Multi-tiered high through-put screen for compounds effective against bacterial biofilm and compounds effective for inhibiting and eradicating bacterial biofilm

    Government of the United States, as represented by the Secretary of the Air Force · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  9. US 10702473

    Liposome formulation for delivery of Wnt signal pathway inhibitor

    Curegenix, Inc. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  10. US 10703746

    Mutant IDH1 inhibitors useful for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  11. US 10703721

    Caffeic acid derivatives and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  12. US 10703698

    Compounds which activate estrogen receptors and compositions and methods of using the same

    The Board of Regents of the University of Texas System · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  13. US 10703816

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  14. US 10695430

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  15. US 10695320

    Compositions comprising urolithin compounds

    Amazentis SA · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  16. US 10696945

    Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells

    China Medical University · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  17. US 10696724

    Activatable interleukin-2 polypeptides

    Werewolf Therapeutics, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  18. US 10696723

    Activatable interleukin 12 polypeptides

    Werewolf Therapeutics, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  19. US 10696718

    Compstatin analogs for treatment of neuropathic pain

    Apellis Pharmaceuticals, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  20. US 10696656

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  21. US 10696689

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  22. US 10696672

    Amino acid compounds and methods of use

    Pliant Therapeutics, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  23. US 10695432

    Solid solution compositions and use in severe pain

    Infirst Healthcare Limited · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  24. US 10696631

    Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.